Your account is not claimed yet. You can sign up with ORCID to claim your account.

Amar Abderrahmani

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 12

Top Venues

Journal of diabetes research

Pharmaceutics

Cells

Cellular and molecular life sciences : CMLS

Univ. Lille

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Univ. Lille Oct 1o 2011

France

Full Professor :: IEMN CNRS UMR 8520

Publications

Michele Lodato, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, Emeline Buissart, Stéphane Dalle, Sabine Szunerits, Jérôme Vicogne, Rabah Boukherroub, Amar Abderrahmani
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes? Cells 12 (6) (2023)
Tomasz Swebocki, Alexandre Barras, Amar Abderrahmani, Kamel Haddadi, Rabah Boukherroub
Deep Eutectic Solvents Comprising Organic Acids and Their Application in (Bio)Medicine. International journal of molecular sciences 24 (10) (2023)
Shakila Behzadifar, Alexandre Barras, Valérie Plaisance, Valérie Pawlowski, Sabine Szunerits, Amar Abderrahmani, Rabah Boukherroub
Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes. Pharmaceutics 15 (4) (2023)
Shakila Behzadifar, Alexandre Barras, Valérie Plaisance, Valérie Pawlowski, Sabine Szunerits, Amar Abderrahmani, Rabah Boukherroub
Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes. Pharmaceutics 15 (4) (2023)
Michele Lodato, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, Emeline Buissart, Stéphane Dalle, Sabine Szunerits, Jérôme Vicogne, Rabah Boukherroub, Amar Abderrahmani
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes? Cells 12 (6) (2023)
Shakila Behzadifar, Alexandre Barras, Valérie Plaisance, Valérie Pawlowski, Sabine Szunerits, Amar Abderrahmani, Rabah Boukherroub
Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes. Pharmaceutics 15 (4) (2023)
Shakila Behzadifar, Alexandre Barras, Valérie Plaisance, Valérie Pawlowski, Sabine Szunerits, Amar Abderrahmani, Rabah Boukherroub
Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes. Pharmaceutics 15 (4) (2023)
Michele Lodato, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, Emeline Buissart, Stéphane Dalle, Sabine Szunerits, Jérôme Vicogne, Rabah Boukherroub, Amar Abderrahmani
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes? Cells 12 (6) (2023)
Sabine Szunerits, Sorin Melinte, Alexandre Barras, Quentin Pagneux, Anna Voronova, Amar Abderrahmani, Rabah Boukherroub
The impact of chemical engineering and technological advances on managing diabetes: present and future concepts. Chemical Society reviews 50 (3) (2021)
Mathie Tenenbaum, Valérie Plaisance, Raphael Boutry, Valérie Pawlowski, Cécile Jacovetti, Clara Sanchez-Parra, Hélène Ezanno, Julien Bourry, Nicole Beeler, Gianni Pasquetti, Valery Gmyr, Stéphane Dalle, Julie Kerr-Conte, François Pattou, Syu-Ichi Hirai, Romano Regazzi, Amélie Bonnefond, Philippe Froguel, Amar Abderrahmani
The Map3k12 (Dlk)/JNK3 signaling pathway is required for pancreatic beta-cell proliferation during postnatal development. Cellular and molecular life sciences : CMLS 78 (1) (2020)
Amar Abderrahmani, Loïc Yengo, Robert Caiazzo, Mickaël Canouil, Stéphane Cauchi, Violeta Raverdy, Valérie Plaisance, Valérie Pawlowski, Stéphane Lobbens, Julie Maillet, Laure Rolland, Raphael Boutry, Gurvan Queniat, Maxime Kwapich, Mathie Tenenbaum, Julien Bricambert, Sophie Saussenthaler, Elodie Anthony, Pooja Jha, Julien Derop, Olivier Sand, Iandry Rabearivelo, Audrey Leloire, Marie Pigeyre, Martine Daujat-Chavanieu, Sabine Gerbal-Chaloin, Tasnim Dayeh, Guillaume Lassailly, Philippe Mathurin, Bart Staels, Johan Auwerx, Annette Schürmann, Catherine Postic, Clemens Schafmayer, Jochen Hampe, Amélie Bonnefond, François Pattou, Philippe Froguel
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes. Diabetes 67 (7) (2018)
Céline Hivelin, Sophie Béraud-Dufour, Christelle Devader, Amar Abderrahmani, Sébastien Moreno, Hamid Moha Ou Maati, Alaeddine Djillani, Catherine Heurteaux, Marc Borsotto, Jean Mazella, Thierry Coppola
Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin. Journal of diabetes research 2016 (2016)
Roberto Salvi, Amar Abderrahmani
Decompensation of β-cells in diabetes: when pancreatic β-cells are on ICE(R). Journal of diabetes research 2014 (2014)
Valérie Plaisance, Gérard Waeber, Romano Regazzi, Amar Abderrahmani
Role of microRNAs in islet beta-cell compensation and failure during diabetes. Journal of diabetes research 2014 (2014)
Hélène Ezanno, Valérie Pawlowski, Saida Abdelli, Raphael Boutry, Valery Gmyr, Julie Kerr-Conte, Christophe Bonny, François Pattou, Amar Abderrahmani
JNK3 is required for the cytoprotective effect of exendin 4. Journal of diabetes research 2014 (2014)
Romano Regazzi, Stephane Dalle, Amar Abderrahmani
Compensatory mechanisms of pancreatic beta cells: insights into the therapeutic perspectives for diabetes. Journal of diabetes research 2014 (2014)

Amar Abderrahmani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amar Abderrahmani